Steven Cohen Fate Therapeutics Inc Transaction History

Point72 Asset Management, L.P.

$39.3 Billion
Q1 2024

A detailed history of Steven Cohen (Point72 Asset Management, L.P.) transactions in Fate Therapeutics Inc stock. As of the latest transaction made, Point72 Asset Management, L.P. holds 1,584,300 shares of FATE stock, worth $5.2 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

1,584,300

Previous 3,489,163 54.59%

Holding current value

$5.2 Million

Previous $13 Million 10.89%

% of portfolio

0.03%

Previous 0.03%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$3.54 - $8.35 $6.74 Million - $15.9 Million	-1,904,863 Reduced 54.59%	1,584,300 $11.6 Million
Q4 2023 Feb 14, 2024	BUY	$1.65 - $3.94 $5.64 Million - $13.5 Million	3,415,762 Added 4653.56%	3,489,163 $13 Million
Q3 2023 Nov 14, 2023	BUY	$2.02 - $5.04 $127,795 - $318,855	63,265 Added 624.16%	73,401 $155,000
Q2 2023 Aug 14, 2023	BUY	$4.76 - $6.59 $48,247 - $66,796	10,136 New	10,136 $48,000
Q4 2020 Feb 16, 2021	SELL	$38.09 - $100.95 $5.77 Million - $15.3 Million	-151,564 Closed	0 $0

Q3 2020 Nov 16, 2020	SELL	$30.41 - $40.5 $5.33 Million - $7.1 Million	-175,272 Reduced 53.63%	151,564 $6.06 Million
Q2 2020 Aug 14, 2020	BUY	$20.21 - $35.23 $6.61 Million - $11.5 Million	326,836 New	326,836 $11.2 Million
Q1 2020 May 15, 2020	SELL	$17.28 - $31.88 $13.5 Million - $25 Million	-782,783 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$13.39 - $20.73 $5.32 Million - $8.24 Million	-397,306 Reduced 33.67%	782,783 $15.3 Million
Q3 2019 Nov 15, 2019	BUY	$15.47 - $22.5 $9.07 Million - $13.2 Million	586,589 Added 98.84%	1,180,089 $18.3 Million
Q2 2019 Aug 14, 2019	BUY	$15.61 - $20.44 $1.46 Million - $1.91 Million	93,500 Added 18.7%	593,500 $12 Million
Q1 2019 May 15, 2019	BUY	$13.15 - $18.71 $6.58 Million - $9.36 Million	500,000 New	500,000 $8.79 Million

Others Institutions Holding FATE

# of Institutions

178

Shares Held

124M

Call Options Held

222K

Put Options Held

48.6K

View Full List

About FATE THERAPEUTICS INC

Ticker FATE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,000,304
Market Cap $318M
Description
Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. Its NK- and T-cell immuno-oncology programs under development include FT516 for the treatment of acute myeloid leukemia (AML) B-cell lymphoma, and advanced solid tumor; FT596 to treat B-cell...

More about FATE

Track Steven Cohen's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.

Account